Thomas Laur - 21 Apr 2022 Form 4 Insider Report for Change Healthcare Inc.

Role
Title: EVP, and President, Technology Enabled Services
Signature
/s/ Robert Zachary Beasley, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
21 Apr 2022
Net transactions value
$0
Form type
4
Filing time
25 Apr 2022, 17:05:08 UTC
Previous filing
19 Apr 2022
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CHNG Stock Option (Right to Buy) Award $0 +271,760 $0.000000 271,760 21 Apr 2022 Common Stock 271,760 $18.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a May 25, 2018 option grant which was previously not required to be reported as a derivative security. On April 21, 2022, the Company approved an additional service-based vesting opportunity for the options. Options to vest in three equal annual installments, subject to the Reporting Person's continued employment through the applicable vesting date, commencing upon the earlier to occur of: (a) the Exit Event or (b) June 30, 2022.

Remarks:

Title: EVP, and President, Technology Enabled Services